AFTX-201
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for AFTX-201, covering 2026-02-23 to 2026-02-23. Get the full timeline:
Most recent: Clinical Trial Update: An AAV Gene Therapy Trial of AFTX-201 in Adults With BAG3-Associated Dilated Cardiomyopathy (DCM) [Phase 1, Phase 2]